These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12679428)

  • 1. Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study.
    Ueland T; Kristo C; Godang K; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1492-6. PubMed ID: 12679428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index.
    Schafroth U; Godang K; Ueland T; Berg JP; Bollerslev J
    J Endocrinol Invest; 2000 Jun; 23(6):349-55. PubMed ID: 10908161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma leptin levels in relation to body composition and body fat distribution in patients with Cushing's syndrome].
    Robaczyk M; Krzyzanowiska-Swiniarska B; Andrysiak-Mamos E; Kulig G; Pilarska K
    Pol Arch Med Wewn; 2003 Nov; 110(5):1299-308. PubMed ID: 16737000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?
    Meier CA; Bobbioni E; Gabay C; Assimacopoulos-Jeannet F; Golay A; Dayer JM
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1184-8. PubMed ID: 11889184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
    Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
    Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.
    Krsek M; Silha JV; Jezková J; Hána V; Marek J; Weiss V; Stepán JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):350-7. PubMed ID: 15009001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of serum leptin levels in Cushing's syndrome.
    Widjaja A; Schürmeyer TH; Von zur Mühlen A; Brabant G
    J Clin Endocrinol Metab; 1998 Feb; 83(2):600-3. PubMed ID: 9467580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
    Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cortisol responsivity to adrenocorticotropic hormone and low plasma levels of interleukin-1 receptor antagonist in women with functional hypothalamic amenorrhea.
    Lindahl MS; Olovsson M; Nyberg S; Thorsen K; Olsson T; Sundström Poromaa I
    Fertil Steril; 2007 Jan; 87(1):136-42. PubMed ID: 17094981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome.
    Masuzaki H; Ogawa Y; Hosoda K; Miyawaki T; Hanaoka I; Hiraoka J; Yasuno A; Nishimura H; Yoshimasa Y; Nishi S; Nakao K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2542-7. PubMed ID: 9253331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism.
    Burt MG; Gibney J; Ho KK
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):436-43. PubMed ID: 16584517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Farrerons J; Webb SM
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3365-71. PubMed ID: 19509101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women.
    Purnell JQ; Brandon DD; Isabelle LM; Loriaux DL; Samuels MH
    J Clin Endocrinol Metab; 2004 Jan; 89(1):281-7. PubMed ID: 14715862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA; Nagy TR; Goran MI; Smith A; Kent E
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
    Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism.
    Cizza G; Lotsikas AJ; Licinio J; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2747-50. PubMed ID: 9253364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 system gene polymorphisms are associated with fat mass in young men.
    Strandberg L; Lorentzon M; Hellqvist A; Nilsson S; Wallenius V; Ohlsson C; Jansson JO
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2749-54. PubMed ID: 16636119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.